文献速递急性肾损伤慢性肾脏病

费罗莫司作为磁共振成像对比剂的当前及潜在影像应用

Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
PubMed 文献 · Kidney Int · 2017-04-20

本文综述了静脉用费罗莫司作为磁共振成像对比剂的特点,与标准钆基对比剂相比,费罗莫司在肾功能受损患者中可行,具有延长血池期和延迟细胞内摄取等影像特征,可能在未来的中枢神经系统、非中枢神经系统器官及心血管系统磁共振成像中发挥关键作用。临床前和临床研究已证明该新型对比剂的总体安全性和有效性,罕见过敏样反应。

要点

  • 费罗莫司作为替代对比剂,在肾功能受损患者中可行。
  • 费罗莫司具有延长血池期和延迟细胞内摄取的影像特征。
  • 临床前和临床研究显示费罗莫司总体安全有效,罕见过敏样反应。

核心结论

  • 费罗莫司具有独特的药理、代谢和影像特性,可能在未来中枢神经系统、非中枢神经系统器官及心血管系统的磁共振成像中发挥关键作用。

研究设计与样本

  • 本文为综述,旨在描述费罗莫司的一般和器官特异性特性,以及其在磁共振成像中应用的优势和潜在陷阱。

主要发现

  • 与标准钆基对比剂相比,费罗莫司作为替代对比剂在肾功能受损患者中可行。
  • 静脉用费罗莫司的影像特征包括延长血池期和延迟细胞内摄取。
  • 临床前和临床研究已证明费罗莫司的总体安全性和有效性,罕见过敏样反应。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Contrast-enhanced magnetic resonance imaging is a commonly used diagnostic tool. Compared with standard gadolinium-based contrast agents, ferumoxytol (Feraheme, AMAG Pharmaceuticals, Waltham, MA), used as an alternative contrast medium, is feasible in patients with impaired renal function. Other attractive imaging features of i.v. ferumoxytol include a prolonged blood pool phase and delayed intracellular uptake. With its unique pharmacologic, metabolic, and imaging properties, ferumoxytol may play a crucial role in future magnetic resonance imaging of the central nervous system, various organs outside the central nervous system, and the cardiovascular system. Preclinical and clinical studies have demonstrated the overall safety and effectiveness of this novel contrast agent, with rarely occurring anaphylactoid reactions. The purpose of this review is to describe the general and organ-specific properties of ferumoxytol, as well as the advantages and potential pitfalls associated with its use in magnetic resonance imaging. To more fully demonstrate the applications of ferumoxytol throughout the body, an imaging atlas was created and is available online as supplementary material.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Toth GB, Varallyay CG, Horvath A, et al. Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. Kidney Int. 2017. PMID: 28434822. doi:10.1016/j.kint.2016.12.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。